Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours
Clinical trial NCT04810208 · TERMINATED
Trial details
- NCT number
- NCT04810208
- Sponsor
- Lidds AB
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-28
- Primary completion
- 2021-10-07
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.